Research and Development
Smart pills ‘set to boom’
March 5, 2014 Medical Communications, Research and Development, Sales and Marketing frost and sullivan, rajan, smart pills, smartpills
Canbex Therapeutics hires chief medical officer


March 5, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canbex Therapeutics
NICE U-turn on Pfizer drug Inlyta
March 5, 2014 Research and Development, Sales and Marketing Kidney cancer, NHS, NICE, Pfizer, axitinib, inlyta
Cobra agrees oncology deal with BioCancell
March 4, 2014 Manufacturing and Production, Research and Development BC-821, Cobra, biocancell, oncology
Clinical studies still not being published
March 4, 2014 Research and Development, Sales and Marketing ABPI, EMA, alltrials, clinical trials, csr
CluePoints appoints three heads
March 4, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cluepoints, colby, polvent, stephenne
Roche lung cancer drug fails
March 3, 2014 Research and Development, Sales and Marketing Cancer, MetMAb, NSCLC, Roche, Tarceva, avastin
dna Medical Communications hires MD
March 3, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing dna Medical Communications, neil flash
Look beyond the screen
March 3, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, cliinical, data, screening, trials
Packer Forbes Communications adds managing director
February 28, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Packer Forbes, joella webber
Novartis extends trial transparency
February 27, 2014 Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Goldacre, Novartis, alltrials, transparency
Novartis to axe Horsham site
February 27, 2014 Manufacturing and Production, Research and Development, Sales and Marketing Horsham, Novartis, closure, cuts, research, restructure
Biotech industry failed by UK, says UCB
February 27, 2014 Research and Development, Sales and Marketing Cimzia, NHS, UCB, biotech, doliveux, tellier, vimpat
Best of Health Awards judges appointed
February 27, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Best of Health, IPA, henderson
InterMune scores in lung trial
February 26, 2014 Research and Development, Sales and Marketing Esbriet, FDA, IPF, InterMune, fvc, lung
Latest content
The evidence bar impacting UK medical cannabis access
Addressing the rheumatic disease diagnostic gap in primary care
